Jacobs John C
SEC insider (Form 3/4/5 filer). CIK 0001820836. President and CEO at NOVAVAX INC (NVAX). 15 reported Form 4/5 transactions since Sep 2024; latest on Mar 3, 2026. Located in GAITHERSBURG, MD.
Companies Jacobs John C has filed insider reports for
- NOVAVAX INC (NVAX): Director, Officer, President and CEO
Jacobs John C
CIK: 0001820836
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NOVAVAX INC
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Mar 3, 2026NVAX
NOVAVAX INC
ExerciseDirect150.2K shares- - Mar 3, 2026NVAX
NOVAVAX INC
Tax PaymentDirect69.3K shares at avg. $9.49$658K - Mar 2, 2026NVAX
NOVAVAX INC
AwardDirectNon-Statutory Stock Option NQ
551.5K shares- - Mar 2, 2026NVAX
NOVAVAX INC
AwardDirectNon-Statutory Stock Option NQ
551.5K shares at avg. $9.09- - Mar 2, 2026NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
367.5K shares- - Mar 1, 2026NVAX
NOVAVAX INC
ExerciseDirect83.3K shares- - Mar 1, 2026NVAX
NOVAVAX INC
Tax PaymentDirect38.5K shares at avg. $10.14$390K - Jan 23, 2026NVAX
NOVAVAX INC
Tax PaymentDirect39.1K shares at avg. $9.17$359K - Jan 23, 2026NVAX
NOVAVAX INC
ExerciseDirect83.2K shares- - Mar 3, 2025NVAX
NOVAVAX INC
AwardDirect2025 Restricted Stock Units RSU
450.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVAX NOVAVAX INC | Exercise | 150,167 | - | $0 | Direct |
| Mar 3, 2026 | NVAX NOVAVAX INC | Tax Payment | 69,288 | $9.49 | $657,543 | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award Non-Statutory Stock Option NQ | 551,500 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award Non-Statutory Stock Option NQ | 551,500 | $9.09 | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award Restricted Stock Units | 367,500 | - | - | Direct |
| Mar 1, 2026 | NVAX NOVAVAX INC | Exercise | 83,333 | - | $0 | Direct |
| Mar 1, 2026 | NVAX NOVAVAX INC | Tax Payment | 38,450 | $10.14 | $389,883 | Direct |
| Jan 23, 2026 | NVAX NOVAVAX INC | Tax Payment | 39,132 | $9.17 | $358,840 | Direct |
| Jan 23, 2026 | NVAX NOVAVAX INC | Exercise | 83,197 | - | $0 | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award 2025 Restricted Stock Units RSU | 450,500 | - | - | Direct |
1-10 of 15 transactions